Sequentially Released Liposomes Enhance Anti-Liver Cancer Efficacy of Tetrandrine and Celastrol-Loaded Coix Seed Oil
Yunyan Chen,Ziwei Zhang,Zhilei Qian,Rui Ma,Minna Luan,Yu Sun
DOI: https://doi.org/10.2147/ijn.s446895
IF: 7.033
2024-01-23
International Journal of Nanomedicine
Abstract:Yunyan Chen, 1, 2 Ziwei Zhang, 1, 2 Zhilei Qian, 3 Rui Ma, 1, 2 Minna Luan, 1, 2 Yu Sun 1 1 School of Pharmacy, Wannan Medical College, Wuhu, 241002, People's Republic of China; 2 Institute of Synthesis and Application of Medical Materials, Wannan Medical College, Wuhu, 241002, People's Republic of China; 3 The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, 210029, People's Republic of China Correspondence: Yunyan Chen; Yu Sun, School of Pharmacy, Wannan Medical College, Wuhu, 241002, People's Republic of China, Tel +86 553 3932492, Email ; Background: A sequential release co-delivery system is an effective strategy to improve anti-cancer efficacy. Herein, multicomponent-based liposomes (TET-CTM/L) loaded with tetrandrine (TET) and celastrol (CEL)-loaded coix seed oil microemulsion (CTM) were fabricated, which showed synergistic anti-liver cancer activities. By virtue of Enhanced Permeability and Retention (EPR) effect, TET-CTM/L can achieve efficient accumulation at the tumor site. TET was released initially to repair abnormal vessels and decrease the fibroblasts, and CTM was released subsequently for eradication of tumor tissue. Methods: TEM (transmission electron microscopy) and DLS (dynamic light scattering) were adopted to characterize the TET-CTM/L. Flow cytometry was adopted to examine the cellular uptake and cytotoxicity of HepG2 cells. The HepG2 xenograft nude mice were adopted to evaluate the anti-tumor efficacy and systemic safety of TET-CTM/L. Results: TEM images of TET-CTM/L showed the structure of small particle size of CTM within large-size liposomes, indicating that CTM can be encapsulated in liposomes by film dispersion method. In in vitro studies, TET-CTM/L induced massive apoptosis toward HepG2 cells, indicating synergistic cytotoxicity against HepG2 cells. In in vivo studies, TET-CTM/L displayed diminished systemic toxicity compared to celastrol or TET used alone. TET-CTM/L showed the excellent potential for tumor-targeting ability in a biodistribution study. Conclusion: Our study provides a new strategy for combining anti-cancer therapy that has good potential not only in the treatment of liver cancer but also can be applied to the treatment of other solid tumors. Keywords: celastrol, tetrandrine, sequentially released liposomes, anti-liver cancer Liposome-based nano drug delivery systems are emerging as one of the most promising anticancer drugs, but still face increasing challenges in the dilemma of chemotherapy. 1,2 On account of the EPR effect, the nano-drug delivery system can reduce the targeting toxicity and enhance the accumulation at the tumor site compared with conventional chemotherapy. 3–6 Commercially available liposomes, such as Doxil ® , Marqibo ® , DepoCyt ® were studied in alternative chemotherapy, have already shown significant advantages in reducing systemic cytotoxicity. Tumor-associated fibroblasts (CAFs) can induce massive collagen deposition and scaffold protein remodeling, resulting in dense tissue and increased osmotic pressure. 7,8 This obstacle hinders the intra-tumoral permeation and therapeutic efficacy of nanomedicine. Therefore, reasonable intervention of CAFs may not only inhibit the tumor-promoting efficacy but also normalize the intra-tumoral delivery pathway of nanomedicine by regulating the tumor microenvironment to achieve better therapeutic efficacy. 9 Tetrandrine, an alkaloid that was extracted from traditional Chinese medicine herb Stephania tetrandra S , displayed significant anti-hepatic fibrosis efficacy. It has been reported that tetrandrine can inhibit the production of TLR-related ligand, which in turn inhibits TLR4-mediated secretion of inflammatory factors such as TGF-β 1 and decreases TGF-β 1 -mediated activation of fibroblasts. Tetrandrine can also inhibit the proliferation of hepatic fibroblasts indirectly by down-regulating the expression of TIMP-1 and MMP, and then reduce the deposition of collagen and the expression of fibrosis-related genes in the extracellular matrix. 10–13 In addition, TET has a very broad range of different pharmacological activities, including anti-inflammatory, anti-rheumatoid arthritis, anti-adipogenic, and so on. 14–25 Celastrol is one of the main active components of Tripterygium wilfordii , which is one of five promising natural drug molecules and has shown excellent activities in the treatment of various cancers, inflammation, and so on. However, due to the non-selective distribution of the drug, its hepatotoxicity, nephrotoxicity, and immunosuppressive -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology